drugset
drugset / Trial / NCT02315833

The Efficacy of L-cysteine in Prevention of Headache Attacks in Migraine Patients

NCT02315833 ↗

Completed 200 enrolled Biohit Oyj The Finnish Funding Agency for Technology and Innovation · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to validate the novel hypothesis that daily use of L-cysteine (Acetium® capsules) is an effective means to decrease the frequency of (or completely abort) the headache attacks in migraine patients.

Timeline

Start
2013-12-17
Primary completion
2019-07-02
Completion
2020-09-07

Drugs

EvaluationDrugModalityDoseRoute
Subject L-cysteine Unknown 100 mg Oral

Indications

migraine disorder